| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $37.14M | $27.62M | $31.38M | $27.69M | $20.52M |
| R&D | $21.18M | $14.12M | $17.33M | $15.08M | $9.21M |
| SG&A | $15.96M | $13.50M | $14.04M | $12.61M | $11.31M |
| Operating Income | -$37.14M | -$27.62M | -$31.38M | -$27.69M | -$20.52M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$34.77M | -$25.50M | -$30.09M | -$26.96M | -$20.61M |
| EPS (basic) | -4.0400 | -0.2000 | -0.2400 | -0.2100 | -0.1800 |
| EPS (diluted) | -4.0400 | -0.2000 | -0.2400 | -0.2100 | – |
| Shares (diluted) | $8.61M | $125.86M | $126.08M | $126.62M | – |